Companies / Intellia Therapeutics, Inc.
Intellia Therapeutics, Inc.
Financials · FY2025
Ownership
140.1M shares outstanding · as of Jul 31, 2026
Ownership
| Insiders | 1.52% | 2,136,465 |
| 10%+ / strategic | 16.38% | 22,959,468 |
| Institutions | 69.10% | 96,833,109 |
| Public float | 12.99% | 18,197,651 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 8
View all →| Insider | % of shares | Shares |
|---|---|---|
Leonard John MCEOPresident and CEO · Director | 0.83% | 1,169,739 |
Cohen Fred EDirector | 0.15% | 216,653 |
Dulac Edward J IIIEVP, Chief Financial Officer | 0.11% | 160,963 |
Basta JamesEVP, General Counsel | 0.11% | 156,794 |
Schultes Birgit CEVP, Chief Scientific Officer | 0.10% | 137,733 |
Lebwohl DavidEVP, Chief Medical Officer | 0.09% | 131,192 |
Clark ElianaEVP, Chief Technical Officer | 0.07% | 93,864 |
Dube Michael PVP, Chief Accounting Officer | 0.05% | 69,527 |
Institutional holders 304
View all →| Holder | Value | % of shares |
|---|---|---|
| $260.72M | 11.00% | |
| $156.26M | 6.59% | |
| $127.72M | 10.14% | |
| $116.96M | 9.28% | |
| $73.44M | 4.09% | |
| $62.65M | 2.64% | |
| $60.33M | 3.36% | |
| $36.56M | 2.03% | |
| $22.83M | 1.27% | |
| $21.09M | 1.67% |
Activity
Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q2 2026 as of | BlackRock, Inc. 13F manager | Add | — | $86.84M | +5.1M +49.94% | 15,409,023 11.00% of shares | high |
| Q2 2026 as of | State Street Corporation 13F manager | Add | — | $47.65M | +2.8M +43.87% | 9,234,987 6.59% of shares | medium |
| Q1 2026 as of | Two Sigma Investments, LP 13F manager | Add | — | $25.73M | +2.0M +74.37% | 4,705,901 3.36% of shares | medium |
| Q1 2026 as of | Arrowstreet Capital, Limited Partnership 13F manager | New | — | $17.91M | +1.4M | 1,397,243 1.00% of shares | medium |
| Q1 2026 as of | Renaissance Technologies LLC 13F manager | Exit | — | $-15.04M | -1.7M -100.00% | — | medium |
| Q3 2025 as of | Farallon Capital Management LLC 13F manager | New | — | $10.49M | +607K | 607,200 0.43% of shares | medium |
| Q4 2025 as of | Farallon Capital Management LLC 13F manager | Exit | — | $-10.49M | -607K -100.00% | — | medium |
| Q1 2026 as of | Jupiter Asset Management Ltd 13F manager | Add | — | $9.53M | +743K +71.60% | 1,781,063 1.27% of shares | medium |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Vanguard Group Inc | Passive13G/A | — |
| State Street Corporation | Passive13G | — |
| Vanguard Group Inc | Passive13G/A | — |
| Contrarius Investment Management Ltd | Passive13G/A | — |
| ARK Investment Management LLC | Passive13G/A | — |
| The Goldman Sachs Group, Inc. | Passive13G/A | — |
| State Street Corporation | Passive13G | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| NTLA | — | 45826J105 |